• Return to Headlines

Shares of CHRS Down 34.2% Since Downtrend Call on Shares

By David Diaz

SmarTrend identified a Downtrend for Coherus Bioscien (AMEX:CHRS) on May 26th, 2017 at $20.13. In approximately 2 months, Coherus Bioscien has returned 34.16% as of today's recent price of $13.25.

In the past 52 weeks, Coherus Bioscien share prices have been bracketed by a low of $12.85 and a high of $31.98 and are now at $13.25, 3% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 2.0% while the 200-day MA has slid 1.5%.

Coherus Biosciences, Inc. is a biopharmaceutical company. The Company develops biosimilar therapeutics to aid patients.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Coherus Bioscien.

Log in and add Coherus Bioscien (CHRS) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights amex:chrs coherus bioscien

Ticker(s): CHRS